LAVA Therapeutics to Participate in the Citizens JMP Life Sciences Conference
LAVA Therapeutics Full Year 2023 Earnings: Revenues Disappoint
LAVA Provides Business Updates and Reports Fourth Quarter and Year-End Financial Results
Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Lags Revenue Estimates
LAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052 (formerly SGN-EGFRd2/LAVA-1223)
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.